Clinuvel Pharmaceuticals Ltd (CUVL) › RevenueClinuvel Pharmaceuticals Ltd (CUVL): RevenueAnnual figures by period end, from SEC filings.$64.32MYear ended 2026-06-302024-06-30: $57.91M2025-06-30: $61.12M2026-06-30: $64.32M$64.32M2024-06-30 Revenue (USD) 2026-06-30Period endedRevenueChange YoYSource filing2026-06-30$64.32M+5.2%2026-10-30, From 2025-07-012025-06-30$61.12M+5.5%2026-10-30, From 2024-07-012024-06-30$57.91Mn/a2026-10-30, From 2023-07-01Other metrics: Cost of RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)